Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06318637 · ClinicalTrials.gov registry record · NA
Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates
A NA study of Newborn, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT06318637: Completed NA study of Newborn, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
NCT06318637 is a NA study of Newborn that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06318637, a NA study of Newborn, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess, via caregiver questionnaire, the acceptability and feasibility of implementing a bedtime routine for newborns.
Primary Outcome
Will collect agreement data to statements on bedtime routine acceptability using a 5-point Likert scale, ranging from strongly agree to strongly disagree. Will collect bedtime routine information, including wash up/bath, massage/apply lotion and quiet activity.
Conditions Studied
Interventions
- OTHER Baby Wash/Shampoo
- OTHER Daily Activities
- OTHER Body Lotion
Study Locations (1)
Texas
- SGS North America, Inc. - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2024-04-18 |
| Est. Completion | 2025-08-12 |
| Phase | NA |
What the finished NCT06318637 record still lists
NCT06318637 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Newborn appearing as the primary indexed condition, and to 3 interventions - of which Baby Wash/Shampoo is the first listed.
NCT06318637 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06318637 about?
NCT06318637 is a clinical study titled "Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates". The purpose of this study is to assess, via caregiver questionnaire, the acceptability and feasibility of implementing a bedtime routine for newborns.
What is the current status of trial NCT06318637?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2024-04-18. Estimated completion is 2025-08-12.
What conditions does trial NCT06318637 study?
This clinical trial studies the following conditions: Newborn.
What interventions are being tested in trial NCT06318637?
The interventions under investigation include: Baby Wash/Shampoo (OTHER), Daily Activities (OTHER), Body Lotion (OTHER).
Who is sponsoring clinical trial NCT06318637?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06318637 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06318637's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI